Home » Topics » BioWorld Science

BioWorld Science
RSS

In dopamine D1 receptor combo, ghrelin is resurrected as Alzheimer's target

Aug. 16, 2019

Soligenix awarded grant to evaluate SGX-942 in pediatric indications

Aug. 16, 2019

CytoDyn provides update on its HIV dose-escalating monotherapy trial of leronlimab

Aug. 16, 2019

Helmholtz Zentrum Munchen, Phio to identify new targets based on sd-rxRNA platform

Aug. 16, 2019

CARB-X awards funding to IBT to expand development of its IBT-V02 vaccine

Aug. 16, 2019

Rozlytrek approved by FDA or two new cancer indications

Aug. 16, 2019

FDA approves new drug combination for highly drug-resistant tuberculosis

Aug. 16, 2019

Cadila Healthcare identifies bacterial DNA topoisomerase II inhibitors

Aug. 16, 2019

New dopamine D3 receptor antagonists synthesized at Shionogi

Aug. 16, 2019

Sunshine Lake Pharma discovers sodium/glucose cotransporter 1 inhibitors

Aug. 16, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026